Malignant neoplasm of uterus, part unspecified. C55 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2019 edition of ICD-10-CM C55 became effective on October 1, 2018.
Malignant neoplasm of uterus, part unspecified C00-D49 2022 ICD-10-CM Range C00-D49 Neoplasms Note Functional activity All neoplasms are classified in this chapter,... C51-C58 2022 ICD-10-CM Range C51-C58 Malignant neoplasms of female genital organs Includes malignant neoplasm of skin of...
2022 ICD-10-CM Codes C55*: Malignant neoplasm of uterus, part unspecified. ICD-10-CM Codes. ›. C00-D49 Neoplasms. ›. C51-C58 Malignant neoplasms of female genital organs. ›. Malignant neoplasm of uterus, part unspecified C55.
Oct 01, 2021 · Malignant neoplasm of cervix uteri, unspecified 2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code C53.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C53.9 became effective on October 1, 2021.
2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code. ICD-10-CM Diagnosis Code Z15.04 [convert to ICD-9-CM] Genetic susceptibility to malignant neoplasm of endometrium. Genetic susceptibility to cancer of endometrium; Genetic susceptibility to endometrium cancer. ICD-10-CM Diagnosis Code Z15.04.
C55: Malignant neoplasm of uterus, part unspecified.
ICD-10 code Z85. 42 for Personal history of malignant neoplasm of other parts of uterus is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-10-CM Code for Malignant (primary) neoplasm, unspecified C80. 1.
ICD-10 code C54. 1 for Malignant neoplasm of endometrium is a medical classification as listed by WHO under the range - Malignant neoplasms .
Family history of malignant neoplasm of other genital organs Z80. 49 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z80. 49 became effective on October 1, 2021.
Overview. While a diagnosis of uterine cancer can be scary, it is important to know that its most common form—endometrial cancer—is highly curable. Uterine cancer is a blanket term for a group of cancers that can develop inside a woman's uterus.
k. Code C80. 1, Malignant (primary) neoplasm, unspecified, equates to Cancer, unspecified.Dec 3, 2018
Definition of malignant 1 : tending to produce death or deterioration malignant malaria especially : tending to infiltrate, metastasize, and terminate fatally a malignant tumor. 2a : evil in nature, influence, or effect : injurious a powerful and malignant influence.
C56. 9 - Malignant neoplasm of unspecified ovary. ICD-10-CM.
The ICD-10-CM code Z90. 711 might also be used to specify conditions or terms like h/o: hysterectomy, history of abdominal hysterectomy or history of hysterectomy for benign disease. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.
9 for Pulmonary embolism without acute cor pulmonale is a medical classification as listed by WHO under the range - Diseases of the circulatory system .
ICD-10 Code: E11* – Type 2 Diabetes Mellitus.
The most common type starts in the endometrium, the lining of the uterus. This type of cancer is sometimes called endometrial cancer . The symptoms of uterine cancer include. unusual vaginal bleeding or discharge.
Malignant neoplasm of uterus, part unspecified C55-. Cancer that forms in tissues of the uterus (the small, hollow, pear-shaped organ in a woman's pelvis in which a fetus develops). Two types of uterine cancer are endometrial cancer (cancer that begins in cells lining the uterus) and uterine sarcoma ...
Two types of uterine cancer are endometrial cancer (cancer that begins in cells lining the uterus) and uterine sarcoma (a rare cancer that begins in muscle or other tissues in the uterus). Primary or metastatic malignant neoplasm involving the uterine corpus and/or the cervix.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
Approximate Synonyms. Adenocarcinoma of endometrium. Cancer of the endometrium. Cancer of the endometrium, adenocarcinoma. Cancer of the endometrium, adenosquamous. Cancer of the endometrium, clear cell. Cancer of the endometrium, mixed mullerian. Cancer of the endometrium, papillary serous.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion '), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous such as tumors in different quadrants of the same breast, codes for each site should be assigned.
When a primary malignancy has been previously excised or eradicated from its site and there is no further treatment directed to that site and there is no evidence of any existing primary malignancy at that site, a code from category Z85, Personal history of malignant neoplasm, should be used to indicate the former site of the malignancy. Any mention of extension, invasion, or metastasis to another site is coded as a secondary malignant neoplasm to that site. The secondary site may be the principal or first-listed with the Z85 code used as a secondary code.
Chapter 2 of the ICD-10-CM contains the codes for most benign and all malignant neoplasms. Certain benign neoplasms , such as prostatic adenomas, may be found in the specific body system chapters. To properly code a neoplasm, it is necessary to determine from the record if the neoplasm is benign, in-situ, malignant, or of uncertain histologic behavior. If malignant, any secondary ( metastatic) sites should also be determined.
Code C80.0, Disseminated malignant neoplasm, unspecified, is for use only in those cases where the patient has advanced metastatic disease and no known primary or secondary sites are specified. It should not be used in place of assigning codes for the primary site and all known secondary sites.
When a pregnant woman has a malignant neoplasm, a code from subcategory O9A.1 -, malignant neoplasm complicating pregnancy, childbirth, and the puerperium, should be sequenced first, followed by the appropriate code from Chapter 2 to indicate the type of neoplasm. Encounter for complication associated with a neoplasm.
There are also codes Z85.6, Personal history of leukemia, and Z85.79, Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues. If the documentation is unclear as to whether the leukemia has achieved remission, the provider should be queried.
Code C80.1, Malignant ( primary) neoplasm, unspecified, equates to Cancer, unspecified. This code should only be used when no determination can be made as to the primary site of a malignancy. This code should rarely be used in the inpatient setting.